tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AZN Stock Latest News

AstraZeneca: Late‑Stage Pipeline Strength, Margin Expansion, and Undervalued Earnings Inflection Justify Buy Rating
RatingsAstraZeneca: Late‑Stage Pipeline Strength, Margin Expansion, and Undervalued Earnings Inflection Justify Buy Rating
22h ago
AZN
AstraZeneca Wraps Real-World Lung Cancer Study, Sharpening Market Insight for AZN Investors
PremiumCompany Announcements
AstraZeneca Wraps Real-World Lung Cancer Study, Sharpening Market Insight for AZN Investors
2d ago
AZN
AstraZeneca Completes Key Japan Safety Study for Imfinzi/Imjudo in Liver Cancer
PremiumCompany Announcements
AstraZeneca Completes Key Japan Safety Study for Imfinzi/Imjudo in Liver Cancer
2d ago
AZN
AstraZeneca Sets Digitally Enabled 2026 AGM with Key Governance and Capital Votes
PremiumCompany Announcements
AstraZeneca Sets Digitally Enabled 2026 AGM with Key Governance and Capital Votes
2d ago
AZN
AstraZeneca price target raised to 16,000 GBp from 15,500 GBp at Guggenheim
PremiumThe Fly
AstraZeneca price target raised to 16,000 GBp from 15,500 GBp at Guggenheim
2d ago
AZN
AstraZeneca, Daiichi Sankyo announce priority review for Enhertu sBLA
PremiumThe FlyAstraZeneca, Daiichi Sankyo announce priority review for Enhertu sBLA
3d ago
AZN
Controversial Prasad leaving FDA, NYT reports
Premium
The Fly
Controversial Prasad leaving FDA, NYT reports
3d ago
AZN
BMY
AstraZeneca Halts Early KRASG12D Cancer Trial, Shifting Focus in Competitive Oncology Race
Premium
Company Announcements
AstraZeneca Halts Early KRASG12D Cancer Trial, Shifting Focus in Competitive Oncology Race
6d ago
AZN
AstraZeneca CEO Receives 101,495 Shares as Long-Term Incentive Award Vests
PremiumCompany Announcements
AstraZeneca CEO Receives 101,495 Shares as Long-Term Incentive Award Vests
6d ago
AZN
AstraZeneca Executives Receive Vested Deferred Share Awards
PremiumCompany Announcements
AstraZeneca Executives Receive Vested Deferred Share Awards
6d ago
AZN
AstraZeneca Grants Long-Term Share Awards to CEO and CFO
PremiumCompany Announcements
AstraZeneca Grants Long-Term Share Awards to CEO and CFO
6d ago
AZN
AstraZeneca’s ATHLOS COPD Trial Nears Readout, Supporting Long-Term Respiratory Upside
PremiumCompany Announcements
AstraZeneca’s ATHLOS COPD Trial Nears Readout, Supporting Long-Term Respiratory Upside
7d ago
AZN
Entera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)
PremiumTipRanks NewswireEntera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)
7d ago
AZN
IBO
Best ETFs to Invest In, According to AI Analyst, 3/4/2026
Premium
Market News
Best ETFs to Invest In, According to AI Analyst, 3/4/2026
7d ago
AZN
AstraZeneca Updates Early Combo Cancer Trial, Keeping Pressure on Immuno-Oncology Rivals
Premium
Company Announcements
AstraZeneca Updates Early Combo Cancer Trial, Keeping Pressure on Immuno-Oncology Rivals
8d ago
AZN
CDT Equity says advancing multiple initiatives to enhance shareholder value
PremiumThe Fly
CDT Equity says advancing multiple initiatives to enhance shareholder value
8d ago
AZN
CDT
AstraZeneca Completes Key Drug Interaction Study for Capivasertib, Easing Safety Overhang
PremiumCompany Announcements
AstraZeneca Completes Key Drug Interaction Study for Capivasertib, Easing Safety Overhang
9d ago
AZN
AstraZeneca price target raised to $219 from $109 at Morgan Stanley
PremiumThe Fly
AstraZeneca price target raised to $219 from $109 at Morgan Stanley
9d ago
AZN
AstraZeneca Confirms Updated Voting Rights Total for Shareholders
PremiumCompany Announcements
AstraZeneca Confirms Updated Voting Rights Total for Shareholders
10d ago
AZN
AIRSUPRA vs. Albuterol: Completed Phase 4 Asthma Study Sets Up Next Catalyst for AstraZeneca
PremiumCompany AnnouncementsAIRSUPRA vs. Albuterol: Completed Phase 4 Asthma Study Sets Up Next Catalyst for AstraZeneca
13d ago
AZN
AstraZeneca Raises $2bn in Three-Tranche Global Bond Offering
Premium
Company Announcements
AstraZeneca Raises $2bn in Three-Tranche Global Bond Offering
14d ago
AZN
Here’s what Wall Street experts are saying about Salesforce ahead of earnings
Premium
The Fly
Here’s what Wall Street experts are saying about Salesforce ahead of earnings
15d ago
AZN
CRM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >